Inventor profile of:

Lawrence Tim FRIEDHOFF

City:

Rivervale, New Jersey

Country:

United States

Published Applications:

12

Last publication date:

2021-06-17

Top Assignees for applications by Lawrence Tim FRIEDHOFF

The entities that hold a legal rights for patent applications filed by inventor FRIEDHOFF Lawrence Tim:

Recent patent applications by FRIEDHOFF Lawrence Tim

Lawrence Tim FRIEDHOFF from Rivervale, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-06-17
US20210177804A1
Human necessities

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HTserotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

#2 | 2021-05-06
US20210128528A1
Human necessities

USE OF 5HT2A INVERSE AGONISTS FOR TREATING PSYCHOSIS

#3 | 2020-12-24
US20200397754A1
Human necessities

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF REM SLEEP BEHAVIOR DISORDER

#4 | 2019-05-30
US20190160043A1
Human necessities

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF REM SLEEP BEHAVIOR DISORDER

#5 | 2019-05-23
US20190151287A1
Human necessities

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE

#6 | 2019-04-18
US20190111052A1
Human necessities

METHODS OF TREATING A NEURODEGENERATIVE DISEASE

#7 | 2019-02-14
US20190046506A1
Human necessities

USE OF 5HT2A INVERSE AGONISTS FOR TREATING PSYCHOSIS

#8 | 2017-08-31
US20170246163A1
Human necessities

METHODS OF IMPROVING BALANCE, GAIT OR BOTH IN PATIENTS WITH NEUROLOGICAL DISEASE

#9 | 2017-01-19
US20170014385A1
Human necessities

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

#10 | 2016-12-15
US20160361296A1
Human necessities

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder

#11 | 2016-11-10
US20160324852A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE

#12 | 2016-11-10
US20160324851A1
Human necessities

METHODS OF TREATING A NEURODEGENERATIVE DISEASE

InventorID:

1702973 ⎘